From: Synthesis, anticancer evaluation, molecular docking and ADME study of novel pyrido[4ʹ,3ʹ:3,4]pyrazolo[1,5-a]pyrimidines as potential tropomyosin receptor kinase A (TrKA) inhibitors
Code
Apoptosis
Necrosis
Total
Early
Late
7b/HepG2
24.89
5.71
13.72
5.46
15b/HepG2
32.51
2.93
20.12
9.46
16a/HepG2
15.33
8.26
4.32
2.75
16c/HepG2
12.07
6.31
3.20
2.56
cont.HepG2
1.38
0.39
0.15
0.84